5000 ORAL Long-term Outcome of HER2-positive (HER2+) Metastatic Breast Cancer (MBC) Patients (pts) Achieving Durable Complete Remission (DCR) After Trastuzumab (T)-containing Chemotherapy (CT)

✍ Scribed by Gullo, G.; Zuradelli, M.; Kelleher, F.; Sclafani, F.; Donovan, N. O'; Lyons, T.; Masci, G.; Santoro, A.; Crown, J.

• Book ID: 122004485
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 57 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(11)71442-3